Early Positive Report of Viloxazine for a Child with Hyperkinetic Autism
Herein, authors report on an ASD child with comorbid ADHD, ID, metabolic syndrome and nocturnal enuresis that failed multiple trials of psychotropic agents for behavioural dyscontrol. Viloxazine adjuventia brought about remarkable improvement spanning different domains. Purported pharmacodynamic mechanisms are briefly discussed. This case represents one of the earliest reports of viloxazine use in ASD.
Authors
- Ahmed Naguy (ORCID: https://orcid.org/0000-0002-6465-456X)
- Nadyah Alayadhi
- Bibi Alamiri (ORCID: https://orcid.org/0000-0001-7133-9069)
- Saxby Pridmore (ORCID: https://orcid.org/0000-0002-9170-1798)
Institutions
- University of Tasmania (AU)
- Kuwait Cancer Control Center (KW)
- Centre for Mental Health (GB)
- Ministry of Health (KW)
Publication Details
- Journal
- Psychopharmacology Bulletin
- Published
- 2025-08-12
- DOI
- https://doi.org/10.64719/pb.4517
- Citations
- 1
- Primary Topic
- Phenothiazines and Benzothiazines Synthesis and Activities
- Type
- article
- Field-Weighted Citation Impact
- 0.81